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Background: Tissue-resident antigen-presenting cells (APC) exert a major influence on the local immune environment.
Microglia are resident myeloid cells in the central nervous system (CNS), deriving from early post-embryonic precursors,
distinct from adult hematopoietic lineages. Dendritic cells (DC) and macrophages infiltrate the CNS during experimental
autoimmune encephalomyelitis (EAE). Microglia are not considered to be as effective APC as DC or macrophages.
Methods: In this work we compared the antigen presenting capacity of CD11c+ and CD11c− microglia subsets with
infiltrating CD11c+ APC, which include DC. The microglial subpopulations (CD11c− CD45dim CD11b+ and CD11c+ CD45dim
CD11b+) as well as infiltrating CD11c+ CD45high cells were sorted from CNS of C57BL/6 mice with EAE. Sorted cells were
characterised by flow cytometry for surface phenotype and by quantitative real-time PCR for cytokine expression. They
were co-cultured with primed T cells to measure induction of T cell proliferation and cytokine response.
Results: The number of CD11c+ microglia cells increased dramatically in EAE. They expressed equivalent levels of major
histocompatibility complex and co-stimulatory ligands CD80 and CD86 as those expressed by CD11c+ cells infiltrating
from blood. CD11c+ microglia differed significantly from blood-derived CD11c+ cells in their cytokine profile, expressing
no detectable IL-6, IL-12 or IL-23, and low levels of IL-1β. By contrast, CD11c− microglia expressed low but detectable
levels of all these cytokines. Transforming growth factor β expression was similar in all three populations. Although
CNS-resident and blood-derived CD11c+ cells showed equivalent ability to induce proliferation of myelin oligodendrocyte
glycoprotein-immunised CD4+ T cells, CD11c+ microglia induced lower levels of T helper (Th)1 and Th17 cytokines, and
did not induce Th2 cytokines.
Conclusions: Our findings show distinct subtypes of APC in the inflamed CNS, with a hierarchy of functional competence
for induction of CD4+ T cell responses.
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Multiple sclerosis (MS) and its animal model experimental
autoimmune encephalomyelitis (EAE) are characterised
by infiltration to the central nervous system (CNS) of
autoantigen-specific T cells, and recruitment of myeloid
cells, including dendritic cells (DC) and macrophages,
leading to development of inflammatory lesions, demyelin-
ation and axonal damage [1,2]. Recognition of usually mye-
lin epitopes is required for initiation and progression of* Correspondence: towens@health.sdu.dk
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article, unless otherwise stated.EAE [1]; however, the mechanisms underlying initiation
and control of T cell responses in CNS inflammation are
less well understood. Two CD4+ T cell subtypes, the IFN-γ
secreting T helper (Th)1 and IL-17 secreting Th17 cells,
have been shown to play a pathogenic role in EAE [1,3],
although neither of the nominal cytokines is absolutely
required [4,5].
Activation of CD4+ T cells is a multistep process
initiated by the appropriate binding of the T-cell receptor
to its cognate antigenic peptide presented by major
histocompatibility complex (MHC) class II molecules
and subsequent stimulation by co-stimulatory molecules
such as CD80 and CD86 on the antigen presenting cellstral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Wlodarczyk et al. Journal of Neuroinflammation 2014, 11:57 Page 2 of 9
http://www.jneuroinflammation.com/content/11/1/57(APC). During the activation process, both T cell and APC
produce cytokines that shape the immune response.
Cytokines that direct Th1 responses include IL-12
and IL-18, while Th17 are directed by transforming
growth factor (TGF)-β, IL-1β, IL-6, and IL-23. Regulatory
T cells, that exert an anti-inflammatory effect, are directed
by TGF-β in the absence of other Th17-inducing signals,
or by IL-10 [1].
The APC responsible for T cell re-activation within
the CNS remain to be precisely identified. DC, infiltrating
macrophages, B cells and CNS-resident microglia can all
express MHC class II and co-stimulatory molecules that
are required for the initiation and progression of EAE
[1]. Of these, DC are the most generally accepted as
‘professional’ APC that can induce an immune response.
The fact that DC in the uninflamed CNS are located
outside the parenchyma, in perivascular locations [6,7],
has contributed to a model whereby T cells receive
pro-infiltratory signals through interaction with DC in
post-capillary perivascular space [8]. However it remains
unclear whether parenchymally located APC, within the
CNS, can provide an equivalent signal for infiltrating
T cells. Results from a number of studies led to the
conclusion that microglia were not as effective APC
as DC or macrophages [1,9,10].
We described a subset of CD11c+ microglia that were
induced in cuprizone-demyelinated or injury-reactive
CNS. These cells shared with CD11c− microglia the
characteristic of an intermediate level of expression of
CD45 that discriminates microglia from blood-infiltrating
cells [11]. Phenotypically similar cells were induced by
experimental synaptic degeneration in the hippocampus
dentate gyrus [12]. Importantly, the cuprizone-induced
CD11c+ microglia were potent APC for a T cell prolifera-
tive response [11].
In this study, we demonstrate that infiltrating CD11c+
cells that include DC, and CNS-resident CD11c+ microglia
sorted from the CNS during EAE and studied directly
ex vivo, express similar levels of the MHC class I and II
molecules, CD80 and CD86. We furthermore show that
both populations are equivalently capable of inducing an
antigen-specific proliferative response from primed T cells.
Whereas infiltrating CD11c+ cells expressed all of the
Th1- and Th17-inducing cytokines tested, CD11c+
microglia only expressed TGF-β and a low level of
IL-1β but not IL-6, IL-12p35 or IL-23p19. Interestingly, in
contrast to CD11c+ microglia, CD11c− microglia did
express IL-6, IL-12p35 and IL-23p19. Correspondingly, T
cell cytokine responses elicited by these three CNS APC
populations differed in magnitude and cytokine profile.
CD11c+ microglia were weak inducers of Th1 and Th17
cytokines, whereas infiltrating CD11c+ cells more strongly
induced both Th1 and Th17 cytokines. CNS-resident
CD11c− microglia induced very weak proliferative andcytokine responses. Thus, the inflamed CNS contains APC
subpopulations with distinct and possibly complementary
capability.
Methods
Mice
Female C57BL/6j bom (B6) mice aged 6 to 8 weeks were
obtained from Taconic Europe A/S, (Lille Skensved,
Denmark) and maintained in the Biomedical Laboratory,
University of Southern Denmark (Odense). All experiments
were approved by the Danish Ethical Animal Care
Committee (approval number 2009/561-1724 and
2012-15-2934-00110).
Active induction of experimental autoimmune
encephalomyelitis
Seven- to eight-week-old female mice were immu-
nised by injecting subcutaneously 100 μl of an emul-
sion containing 100 μg of myelin oligodendrocyte
glycoprotein (MOG)p35–55 (Department of Biochemistry
and Molecular Biology, University of Southern Denmark,
Odense) in incomplete freunds adjuvant (DIFCO,
Alberstslund, Denmark) supplemented with 400 μg
H37Ra Mycobacterium tuberculosis (DIFCO). Bordetella
pertussis toxin (300 ng; Sigma-Aldrich, Brøndby, Denmark)
in 200 μl of PBS was injected intraperitoneally at day 0 and
day 2. Animals were monitored daily from day 5 and scored
on a 6-point scale as follows: 0, no symptoms; 0.5, partial
loss of tail tonus; 1, complete loss of tail tonus; 2, difficulty
to right, 3, paresis in one or both hind legs; 4, paralysis in
one or both hind legs; 5, front limb paresis; 6, moribund.
About 75% of the mice showed symptoms of EAE. Severe
EAE usually developed 14 to 18 days after immunisation
and was defined as a score of 3 to 5.
Isolation of central nervous system antigen presenting
cells, spleen dendritic cells and T cells
To isolate mononuclear cells from the CNS, mice were
anaesthetised with 0.2 mg pentobarbital (200 mg/ml;
Glostrup Apotek, Glostrup, Denmark) per gram of
mouse and intracardially perfused with ice-cold PBS
when they showed symptoms of severe EAE. CNS tissue
was collected and a single cell suspension was generated
by forcing through a 70 μm cell strainer (BD Biosciences,
Albertslund, Denmark). Mononuclear cells were collected
after centrifugation on 37% Percoll (GE Healthcare
Bio-sciences AB, Brøndby, Denmark). They were then
first incubated with anti-Fc receptor (Clone 2.4G2; 1 μg/ml;
BD Pharmingen,Albertslund, Denmark) and Syrian hamster
IgG (50 μg/ml; Jackson Immuno Research Laboratories
Inc., Skanderborg, Denmark) in PBS 2% fetal bovine serum
(FBS), then with anti-CD45, anti-CD11b and anti-CD11c
antibodies (Table 1) in PBS 2% FBS. Cell populations were
gated based on isotype control antibodies as CD45dim
Table 1 Antibodies used in this study
Antibody Clone Provider
PerCP-Cy5.5 -anti-mouse CD11b M1/70 Biolegend
Biotinylated- anti-mouse CD11c HL3 BD Pharmingen
FITC- anti-mouse CD80 (B7.1) 16-10A1 Biolegend
FITC- anti-mouse CD86 (B7.2) GL1 Biolegend
FITC- anti mouse I-Ab (MHC class II) 25-9-17 Biolegend
FITC- anti mouse H2-Kb (MHC Class I) AF6-88.5 Biolegend
PE- anti-mouse CD45 30-F11 Biolegend
MHC, major histocompatibility complex. BD Pharmingen, Albertslund,
Denmark; Biolegend, Copenhagen, Denmark.
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CD11c+ (CD11c+ microglia) and CD45high CD11c+ and
were sorted on a FACSVantage™ or FACSAria™ III cell
sorter (BD Biosciences).
To isolate spleen DC, naive B6 mice were killed by
cervical dislocation. Spleens were removed and dissociated
by forcing through a 70 μm cell strainer. Erythrocytes
were lysed with 0.83% NH4Cl. DC were isolated by
magnetic separation using CD11c nanobeads (Stemcell
Technologies, Grenoble, France). Final purity was 85
to 90%.
T cells for proliferation assay were isolated from mice
with severe EAE. Lymph nodes were dissociated by
forcing through a 70 μm cell strainer and CD4 T cells
were isolated by magnetic separation using a CD4
negative selection kit (Stemcell Technologies). Final
purity was 90 to 95% CD4 cells.
Flow cytometry
Cells were first incubated with anti-Fc receptor and
Syrian hamster IgG in PBS, 2% FBS, 0.1% sodium
azide then with cell surface marker specific antibodies
in PBS, 2% FBS, 0.1% sodium azide as specified in
Table 1. Cells stained with biotinylated antibodies were
incubated with streptavidin-fluorochrome conjugates
(Biolegend, Copenhagen, Denmark). We used the same
gating strategy as for fluorescence-activated cell sorting
(FACS) and appropriate isotype control antibodies. Data
were collected on a FACSCalibur™ or LSRII™ flow
cytometer (BD Biosciences) and analyzed using FACSDiva™
software version 6.1.2 (BD Biosciences).
Proliferation assay
Primed T cells were stained with 2 μM CFSE (Sigma-
Aldrich). T cells (2 × 105) from each stained preparation
were cultured with CNS APC (5 × 104) with or with-
out 25 μg/ml MOGp35–55 peptide in RPMI Glutamax
(Invitrogen, Nærum, Denmark) supplemented with
10% FBS, 50 U/ml penicillin-streptomycin (Invitrogen)
and 50 μM β-mercaptoethanol (Invitrogen). Supernatantswere collected for cytokine assay at day 1. Three days after
initiation of the co-culture, cells were harvested, stained
with an anti-CD4 antibody and CFSE dilution was
analyzed by flow cytometry.
Cytokine assay
IL-17A and IFN-γ were measured in the culture superna-
tants from the APC-T-cell cultures using a BD cytometry
bead array (CBA) Th1/Th2/Th17 CBA kit following the
manufacturer’s instructions (BD Biosciences).
RNA extraction, quantitative real-time PCR
Sorted CD11c+ microglia, CD11c− microglia and CD45high
CD11c+ cells were placed in RLT buffer (Qiagen,
Copenhagen, Denmark) and total RNA was extracted using
RNeasy columns as per manufacturer’s protocol (Qiagen).
Reverse transcription was performed with M-MLV reverse
transcriptase (Invitrogen) according to the manufacturer’s
protocol.
Quantitative real-time PCR (qRT-PCR) was performed
with 1 μl cDNA in a 25 μl reaction volume containing
Maxima® Probe/ROX qPCR Master mix (Fermentas, St
Leon-rot, Germany), forward and reverse primers (800 nM;
from TAG Copenhagen A/S, Frederiksberg, Denmark) and
probe (200 nM; Applied Biosystems, Nærum, Denmark,
and TAG Copenhagen A/S). Primer and probe sequences
were as follows: CCR2 - Forward: GAAGTATCCAAGAG
CTTGATGAAGG; Reverse: CAAGCTCCAATTTGCTT
CACAC; Probe: CCACCACACCGTATGACT. TGFβ -
Forward: TGACGTCACTGGAGTTGTACGG; Reverse:
GGTTCATGTCATGGATGGTGC; Probe: TTCAGCGC
TCACTGCTCTTGTGACAG. IL-1β - Forward: CTTGG
GCCTCAAAGGAAAGAA; Reverse: AAGACAAACCGT
TTTTCCATCTTC; Probe: AGCTGGAGAGTGTGGAT.
IL-6 - Forward: TATGAAGTTCCTCTCTGCAAGAGA;
Reverse: TAGGGAAGGCCGTGGTT; Probe: CCAGCAT
CAGTCCCAAGAAGGCAACT. IL-23p19 - Forward: TC
TCTGCATGCTAGCCTGGAA; Reverse: ACAACCATC
TTCACACTGGATACG; Probe: CGGGACATATGAATC
TA. IL-12p35 - Forward: AAGACATCACACGGGACCA
AA; Reverse: CAGGCAACTCTCGTTCTTGTGTA; Probe:
CAGCACATTGAAGACCTGTTTACCACTGGA.
PCR reactions were done on an ABI Prism 7300
Sequence Detection System (Applied Biosystems).
Results were expressed relative to 18S rRNA (2ΔCT method)
as endogenous control (TaqMan® Ribosomal RNA control
Reagents kit; Applied Biosystems). cDNA was diluted 1/500
for 18S rRNA analysis.
Statistical analysis
All experiments were repeated at least three times and
data are presented as means ± SEM. Statistical significance
was assessed using the two-tailed Mann–Whitney U-test
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Results
Different central nervous system antigen presenting cells
populations emerge during experimental autoimmune
encephalomyelitis
The presence of potential APC in the CNS of both
unchallenged and immunised mice was evaluated by
their expression of CD11c. Cells were isolated from
perfused CNS from either unchallenged B6 mice or
from immunised B6 mice with severe EAE. CNS
mononuclear cells were analyzed by flow cytometry
for expression of CD45 and CD11c. We used relative
CD45 levels to discriminate between blood-derived
infiltrated (CD45high) and resident microglia (CD45dim) as
previously described [11,12].
We did not detect any CD45high CD11c+ cells in CNS
of unmanipulated mice. A small population of CD11c+
CD45dim microglia was detected (1.7 ± 0.5% of the
total microglia population; Figure 1A,B). ImmunisationFigure 1 Comparison of microglia and infiltrating cells in the central
profiles of individual central nervous system suspensions prepared from contro
(EAE) showing staining for CD11c and CD45. Vertical line indicates isotype con
cells expressing CD11c (A). Flow cytometry analysis from six combined experim
percentage from total microglia (B). CD11c+ microglia showed an increased ex
expressing cells (C). Quantitative real-time PCR analysis shows significantly lowe
CD11c+ cells (D). Data are presented as a means ± SEM of six individual experimwith MOGp35–55 resulted in increased proportions of
CD11c-expressing cells in the CNS, including an increase
in CD11c+ microglia (Figure 1A,B) and appearance of
blood-derived CD45high CD11c+ cells (Figure 1A).
Activated microglia have been described to express
increased levels of CD45 [13], so it was important to
exclude such populations from the cells we analyzed
as CD45high. We did observe increased CD45 expression
on CD11c+ microglia compared with microglia that did not
express CD11c, but as a population they remained distin-
guishable from the blood-derived cells that expressed a high
level of CD45 (Figure 1C). Recently, resident microglia were
described as lacking the chemokine receptor CCR2 and
expressing CX3CR1 [14]. We confirmed that CD45dim
CD11b+ CD11c+ cells are CCR2− microglia by qRT-PCR
analysis of RNA isolated from FACS-sorted cells. In
contrast to CD45high CD11c+ cells, neither CD11c− nor
CD11c+ microglia expressed CCR2 (Figure 1D). Moreover,
in CX3CR1 eGFP knockin mice, using a different
experimental system, CX3CR1 was expressed by both
CD11c− and CD11c+ microglia (data not shown).nervous system during inflammation. Representative flow cytometry
l mice or mice with severe experimental autoimmune encephalomyelitis
trol. Cytometry profile shows increase of both microglia and infiltrating
ents shows a significant increase of CD11c+ microglia presented as a
pression of CD45, but the expression did not reach the level of CD45high
r expression of CCR2 in both population of microglia than in CD45high
ents (n≥ 13). ***P < 0.001.
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CD86 expression
Expression of MHC class II and co-stimulatory molecules
CD80 and CD86 is synonymous with the ability to present
antigen, and their expression level can be used to indicate
APC maturation state. Freshly isolated CD11c+ microglia
and CD45high CD11c+ cells from mice with severe EAE
showed equivalent levels of expression of MHC class I
and II molecules (Figure 2), but both were significantly
lower than on spleen-derived CD11c+ cells (Figure 2).
Co-stimulatory molecules CD80 and CD86 were likewise
expressed at similar levels on CD11c+ microglia and
CD45high CD11c+ cells but, in contrast to MHC class I
and II molecules, they were expressed at similar levels
as on spleen-derived CD11c+ cells (Figure 2). CD11c−
microglia expressed significantly lower levels of all ofFigure 2 CD11c+ microglia resemble CD45high CD11c+ cells in express
activation. Isolated cells from B6 mice with severe experimental autoimmune
(MHC) class I, MHC class II, CD80 and CD86 and analyzed by flow cytometry. Fo
were gated as CD45dim CD11b+, CD11c−, CD45dim CD11b+, CD11c+ and CD45h
control. Data are presented as means ± SEM of three individual experiments (n
Intensity – background.these molecules. Thus, the inflamed CNS contains three
potential APC populations, two of which express CD11c
and equivalent levels of co-stimulatory molecules to
splenic APC.
CD45high CD11c+ cells but not CD11c+ microglia express
Th1 and Th17 promoting cytokines during experimental
autoimmune encephalomyelitis
To investigate cytokine expression profile in APC in
the CNS of mice with severe EAE we used qRT-PCR
to measure transcripts for Th17- and Th1-inducing
cytokines in FACS-sorted cells. CD45high CD11c+ cells
expressed a higher level of the Th17-inducing cytokines
IL-1β, IL-6 and IL-23 than microglia; however, all of them
expressed similar levels of TGF-β (Figure 3). In contrast
to CD11c− microglia, expression of IL-6 and IL-23 in
CD11c+ microglia was undetectable. CD45high CD11c+ion of molecules needed for antigen presentation and T-cell
encephalomyelitis were stained for major histocompatibility complex
r comparison of central nervous system antigen presenting cells, cells
igh CD11c+. CD11c+ cells from the spleen (spl. DC) were used as positive
= 10). ns, Non-significant differences (P> 0.05). NetMFI, Median Fluorescent
Figure 3 Cytokine expression profile in antigen presenting cells from the central nervous system of mice with experimental
autoimmune encephalomyelitis. Expression of IL-1β, IL-6, IL-12p35, IL-23p19, and transforming growth factor (TGF)β in fluorescence-activated
cell sorted antigen presenting cells (CD11c+ microglia, CD11c− microglia and CD45high CD11c+) from the central nervous system was analyzed by
quantitative real-time PCR. Data are presented as means ± SEM of three individual experiments (n≥ 5). ns, Not significant; *P < 0.05; **P < 0.01. ND,
not detected.
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cytokine IL-12 than the other cell subsets (Figure 3), and
in fact this cytokine was undetectable in CD11c+ microglia.
CD11c+ microglia and CD45high CD11c+ cells show similar
ability to induce proliferation of myelin-specific T cells
The ability to reactivate CNS-targeting T cells was
evaluated by the induction of proliferative response of
MOG-immunised CD4+ T cells. CNS APC populations
were sorted by flow cytometry. Their ability to induce
proliferation in response to MOGp35–55 was measured in
cultures of CD4+ T cells isolated from mice with severe
EAE. Both CD11c+ microglia and CD45high CD11c+ cellsinduced proliferation of MOGp35–55 primed T cells
(Figure 4). Proliferative responses induced by CD11c+
microglia and CD45high CD11c+ cells were similar, though
neither of them was comparable to the response to CD11c+
cells from spleen (Figure 4). Microglia that did not express
CD11c also induced proliferation of primed CD4+ T cells,
but at a significantly lower level than CD11c+ microglia
(Figure 4).
CD11c+ microglia induce a distinct cytokine profile in
activated T cells
To compare the ability of CD11c+ microglia and CD45high
CD11c+ cells to induce cytokine release when presenting
Figure 4 Relative efficiency of central nervous system and
spleen antigen presenting cells in stimulating proliferation of
myelin-specific CD4 T cells. Proliferation of CD4 T cells sorted from
B6 mice with severe experimental autoimmune encephalomyelitis (EAE).
Splenic CD4+ T cells from myelin oligodendrocyte glycoprotein (MOG)
p35–55 immunised B6 mice with severe EAE were isolated using magnetic
beads and cultured with antigen presenting cells (CD11c− microglia,
CD11c+ microglia, CD45high CD11c+ cells and spleen-derived dendritic
cells (spl. DC), with (black bars) or without (white bars) MOGp35–55.
Proliferation was measured by CFSE dilution assay. Data are presented as
means ± SEM of three individual experiments (n ≥ 9 ). ns, Non-significant
differences (P> 0.05).
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cells with specific antigen. T cells were cultured with
CNS-derived CD11c+ microglia, CD11c− microglia,
CD45high CD11c+ cells or splenic CD11c+ cells, in the pres-
ence of MOGp35–55. After 24 hours, IFN-γ and IL-17A
levels in culture supernatants were quantified using CBA.
CD11c− microglia induced the weakest IFN-γ (Figure 5A)
and IL-17A (Figure 5B) response of all the sorted APC
populations. CD11c+ microglia were much more efficient
than CD11c− microglia at inducing release of both
cytokines by T cells. Nevertheless they were markedly
less effective than CD45high CD11c+ cells in this regard
(Figure 5). None of the CNS-derived APC were comparable
to CD11c+ cells derived from spleen in induction of Th1 or
Th17 cytokines (Figure 5). As verification that IL17A in the
cultures derived from CD4+ T cells and not from
APC, RT-PCR showed no (microglia) or almost undetect-
able (CD45high cells) IL17A message in cell-sorted popula-
tions from CNS of mice with EAE (data not shown).We
also assayed IL-4 and IL-10 in the cultures. Very low
levels of those cytokines were induced by all of the
APC (data not shown).
Discussion
We show that three different populations of potential
APC can be isolated from the CNS of mice with EAE.
These are individual and distinct in terms of their abilityto promote CD4+ T cell proliferation as well as to induce
pro-inflammatory cytokines. Infiltrating CD11c+ cells
and an inflammation-associated subset of CNS-resident
CD11c+ microglia show equivalent and potent ability to
induce proliferation of antigen-primed CD4+ T cells.
However they differ in their expression of Th1- and
Th17-inducing cytokines and in their quantitative ability
to induce such T cell responses, CD11c+ microglia
being noticeably less effective. In contrast to these,
CNS-resident CD11c− microglia express low levels of
MHC II and co-stimulatory molecules and are poor
inducers of T cell proliferation. Despite higher expression
of Th1- and Th17-inducing cytokines than their CD11c+
counterparts, they do not induce meaningful Th1 or
Th17 responses. The distinct cytokine-producing and
response-inducing capabilities of these APC subpopula-
tions identify the complexity of the inflammatory milieu
in the CNS in diseases such as MS.
The need for parenchymal APC is based on the funda-
mental immunological principle of reactivation for CD4+ T
cell effector function within the target tissue. A role for DC
in directing T cell transit from the perivascular space in
postcapillary venules has been proposed [10,15]. The
possibility that such T cells would exert adequate
effector function to induce pathology immediately
after crossing the glia limitans cannot be excluded.
However, competent microglia are also required for
EAE and microglia have been shown to induce final
effector CD4+ T cell response [9,16]. Furthermore,
reactivation of effector function in T cells that migrate
deeper than the juxtavascular zone would either
require co-infiltrating or already-resident APC. Such
considerations motivated our study. Our findings confirm
the importance of co-infiltrating CD11c+ APC for T cell
response in the CNS, but also identify CNS-resident
CD11c+ APC that can mediate a qualitatively similar
outcome.
Despite lack of expression of most of the cytokines
that are conventionally associated with Th1 and Th17
induction, CD11c+ microglia could nevertheless induce
both IFN-γ and IL-17A in vitro, although at low levels.
IL-17A induction can be explained by the production of
TGF-β and IL-1β by CD11c+ microglia. Expression of
TGF-β was equivalent to that in infiltrating CD11c+
populations and levels of IL-1β were likely sufficient to
override the induction of regulatory T cells [17]. The
induction of a functional Th17 response by IL-1β + TGF-β
producing CD11c+ microglia that we observed may then
reflect the supplementing contribution of IL-6 or IL-23
produced either by other APC contaminating the T cell
population, or by in vitro induction in microglial
APC. IL-12-independent induction of Th1 responses
has been described that depends on Type I IFN and
IL-18 production by APC [18]. Microglia are known
Figure 5 Cytokine induction by central nervous system antigen presenting cells in primed CD4 T cells. Fluorescence-activated cell sorted
CD4+ T cells from myelin oligodendrocyte glycoprotein (MOG)p35–55 immunised B6 mice with severe experimental autoimmune encephalomyelitis
were co-cultured with antigen presenting cells (CD11c− microglia, CD11c+ microglia, CD45high CD11c+ cells and spleen-derived dendritic cells (spl. DC)
in the presence of MOGp35–55 peptide. The cytokines IFN-γ and IL-17A from supernatants were quantified by cytokine bead array. Data are presented
as means ± SEM of three individual experiments (n≥ 9). ns, Not significant; *P < 0.05; **P < 0.01.
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likely explanation for the Th1 responses we observed
in vitro. Taken together, the observation is that both
infiltrating APC and CNS-resident CD11c+ microglia
can induce Th1 and Th17 responses, but possibly by
different routes. How these different routes influence the
outcome of CNS inflammation will require increased
knowledge of the effect of these induction pathways on
the effector CD4+ T cell response.
Thus, CD11c+ microglia potently induce T cell prolifera-
tion but are weak inducers of Th1 and Th17 differentiation,
due to lack of expression of necessary cytokines. At the
same time, CD11c− microglia are poor inducers of T cell
expansion but do produce Th1- and Th17-inducing
cytokines. Since both subsets of microglia co-exist
during neuroinflammation it is likely that they synergise to
drive T cell proliferation and Th1 and Th17 differentiation,
and so together may function as equivalently effective
CNS-resident APC to the infiltrating CD11c+ cells.
Emergence of the CD45dimCD11c+ subset primarily
overrides a deficit in induction of T cell expansion.
The infiltrating CD11c+ population contained DC. It is
noteworthy that their ability to promote T cell proliferation
not only was equivalent to that of CD11c+ microglia, but
that both were markedly less effective than splenic
DC-containing populations. Neither DC population
was characterised in any more detail and it is possible
that this difference reflects varying proportions of
other CD11c+ cells such as macrophages or granulocytes
which produced a quantitative bias. Alternatively, the
CNS is known for its immune quiescence, including
downregulation of MHC on infiltrating cells [22], and it is
possible that the activity of DC that enter the CNS ismodulated by the local microenvironment. The relatively
high levels of neuronal-derived TGF-β in the CNS
have been shown to be responsible for deviation of T
cell responses towards a regulatory outcome [23], as
well as on microglia [24], and there may be analogous
effects on DC.
DC-like CD11c+ microglia with neurogenic potential
were induced by glatiramer acetate in a transgenic
mouse model for Alzheimer’s disease [25]. Other
descriptions of phenotypically DC-like microglia in CNS
have not discriminated on the basis of relative CD45
levels or other markers that would differentiate them
from actual DC or other CD11c+ leukocytes [26].
Microglia derive from mesodermal progenitors in the
yolk sac that colonise the CNS early in foetal development
[27]. They are ontogenically distinct from other
mononuclear phagocytic cells, being colony stimulating
factor-1-independent [27] and CCR2− CX3CR1+ [14]. The
origin of the CD11c+ subset of microglia is of interest. In
this study we verified that the two CD11c+ populations
that emerge in the inflamed CNS in EAE are ontogenically
as well as functionally and phenotypically distinct. Our
previous data from study of cuprizone demyelination
suggested that CD11c+ microglia arise through proliferative
expansion of a small pre-existing pool [11]. Many studies
show an increase of microglia via proliferation during
EAE [28-30]. We consider it unlikely that CD11c+
microglia increase at the cost of the entire microglia
population, but that they are part of a general microglial
expansion, although perhaps more favoured under certain
circumstances.
The CNS-resident CD11c+ microglial subset has by
now been described under demyelinating, degenerative
Wlodarczyk et al. Journal of Neuroinflammation 2014, 11:57 Page 9 of 9
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as an important component of innate CNS response.
Conclusion
Our findings show that the CNS contains different
populations of APC during EAE with a hierarchy of
functional competence for induction of CD4+ T cell
responses. The relative activity of these APC reflects
lineage as well as local microenvironment. The complexity
of the inflammatory milieu in EAE reinforces the
uniqueness of the CNS as a site for induction and
target of autoimmune response.
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